Weighing in on Optimal Management of VTE in Patients With Obesity

Share

Program Content

Activities

  • Preventing Recurrent VTE in Persons with Obesity
    Preventing Recurrent VTE in Persons with Obesity
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 09, 2022

    Expires: May 08, 2023

  • Managing VTE After Bariatric Surgery
    Managing VTE After Bariatric Surgery
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 23, 2022

    Expires: May 22, 2023

  • Weighing in on Optimal Management of VTE in Patients With Obesity
    Weighing in on Optimal Management of VTE in Patients With Obesity
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2022

    Expires: April 14, 2023

  • Weighing in on Optimal Management of VTE in Patients With Obesity
    Weighing in on Optimal Management of VTE in Patients With Obesity
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2022

    Expires: April 14, 2023

  • VTE in Patients With Obesity
    Weighing in on Optimal Management of VTE in Patients With Obesity
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2022

    Expires: April 14, 2023

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Bristol Myers Squibb

Bristol Myers Squibb

Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Pfizer Alliance

Pfizer Alliance